The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study
JavaScript is disabled for your browser. Some features of this site may not work without it.
The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study
Ak MA; Ak MA; Sahip B; Geduk A; Ucar MA; Kale H; Hacibekiroglu T; Polat MG